Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Dr. Christopher Li receives the Helen G. Edson Endowed Chair for Breast Cancer Research
Epidemiologist is working to improve early detection of breast cancer
What’s new in breast cancer research? San Antonio conference goes hybrid for 2021
Hutch researchers look at overdiagnosis, cardiotoxicity of chemotherapy, cost of a new surveillance method and more
Breast cancer early detection and diagnostic capacity in Uganda
From the Duggan Group, Public Health Sciences Division
How working nights and sleeping days can impact our health, cancer risk
New Fred Hutch study sheds more light on how shift work damages our health — and points toward a potential workaround
Poor adolescent eating habits and breast cancer risk
From the Harris Lab, Public Health Sciences Division.
Health disparities workshops build bridges to better serve marginalized communities
Health disparities workshops build bridges to better serve marginalized communities
High blood levels of vitamin D linked to reduced estrogen – and potentially lower breast cancer risk
Study found the hormone-lowering effect to be independent of weight loss
New breast cancer vaccine ‘promising but not ready for prime time’
Vaccine potentially could be used in the majority of breast cancer patients
‘I have the chance to fight back’: Choosing a preventive double mastectomy
How one BRCA1-positive woman decided to have both breasts removed to lower her risk of breast cancer
NCI awards $11.5 million to Fred Hutchinson Cancer Research Center to lead breast cancer research consortium
Projects include developing targeted therapies to treat drug-resistant tumors
10 tips for breast cancer prevention
First in a weekly series of tips during National Breast Cancer Awareness Month
Predicting the path of resistance
New study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy drugs